Factors affecting hospital stay in psychiatric patients: The role of active comorbidity

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Douzenis, Athanassios ^a   Seretis, Dionysios ^b   Nika, Stella ^a   Nikolaidou, Paraskevi ^a   Papadopoulou, Athanassia ^a   Rizos, Emmanouil N ^a   Christodoulou, Christos ^a   Tsopelas, Christos ^c   Mitchell, Dominic ^d   Lykouras, Lefteris ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b University of Bath   (United Kingdom)

^c Psychiatric Hospital of Attika Dafni   (Greece)

^d University of Bath   (United Kingdom)

Author keywords

Bipolar; Hospital stay; Physical comorbidity; Referral; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BIPOLAR DISORDER; COMORBIDITY; FEMALE; GREECE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MALE; MIDDLE AGED; NONPARAMETRIC TEST; PATIENT REFERRAL; PREVALENCE; REGRESSION ANALYSIS; RISK FACTOR; SCHIZOPHRENIA; STATISTICS;

ADOLESCENT; ADULT; AGED; BIPOLAR DISORDER; COMORBIDITY; FEMALE; GREECE; HUMANS; INPATIENTS; LENGTH OF STAY; MALE; MIDDLE AGED; PREVALENCE; REFERRAL AND CONSULTATION; REGRESSION ANALYSIS; RISK FACTORS; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC;

EID: 84862275404     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-166     Document Type: Article

References (48)

1. Do psychiatric departments in general hospitals have an impact on the physical health of mental patients? Lykouras L, Douzenis A, Curr Opin Psychiatry 2008 21 4 398 402 10.1097/YCO.0b013e32830079d0 18520746
2. Physical health and schizophrenia. Mitchell AJ, Malone D, Curr Opin Psychiatry 2006 19 4 432 437 16721177
3. Diet, smoking and cardiovascular risk in people with schizophrenia: Descriptive study. McCreadie RG, Br J Psychiatry 2003 183 6 534 539 10.1192/bjp.183.6.534 14645025
4. Medical co-morbidity risk factors and barriers to care for people with schizophrenia. Muir-Cochrane E, J Psychiatr Ment Health Nurs 2006 13 4 447 452 10.1111/j.1365-2850.2006.01002.x 16867129
5. The Association of Medical Comorbidity in Schizophrenia with Poor Physical and Mental Health. Dixon L, Postrado L, Delahanty J, Fischer PJ, Lehman A, TheJ Nerv Ment Dis 1999 187 8 496 502 10.1097/00005053-199908000-00006
6. Psychiatric and Medical Comorbidities of Bipolar Disorder. Krishnan KRR, Psychosom Med 2005 67 1 1 8 10.1097/01.psy.0000151489.36347.18 15673617
7. Medical Comorbidity in Bipolar Disorder: Implications for Functional Outcomes and Health Service Utilization. McIntyre RS, Konarski JZ, Soczynska JK, Wilkins K, Panjwani G, Bouffard B, et al. Psychiatr Serv 2006 57 8 1140 1144 10.1176/appi.ps.57.8.1140 16870965
8. Cardiovascular Disease and Metabolic Risk Factors in Male Patients With Schizophrenia, Schizoaffective Disorder, and Bipolar Disorder. Kilbourne AM, Brar JS, Drayer RA, Xu X, Post EP, Psychosomatics 2007 48 5 412 417 10.1176/appi.psy.48.5.412 17878500
9. Medical comorbidity in bipolar disorder: relationship between illnesses of the endocrine/metabolic system and treatment outcome. Kemp DE, Gao K, Chan PK, Ganocy SJ, Findling RL, Calabrese JR, Bipolar Disord 2010 12 4 404 413 10.1111/j.1399-5618.2010.00823.x 20636638
10. Medical Comorbidity in Psychiatric Inpatients: Relation to Clinical Outcomes and Hospital Length of Stay. Lyketsos CG, Dunn G, Kaminsky MJ, Breakey WR, Psychosomatics 2002 43 1 24 30 10.1176/appi.psy.43.1.24 11927754
11. Factors Influencing Length of Hospital Stay. Mezzich JE, Coffman GA, Hosp Community Psychiatr 1985 36 12 1262 1270
12. A Review of Issues Surrounding Length of Psychiatric Hospitalization. Caton CLM, Gralnick A, Hosp Community Psychiatr 1987 38 8 858 863
13. Diagnosis-related groups and general hospital psychiatry: the APA Study. English J, Sharfstein S, Scherl D, Astrachan B, Muszynski I, Am J Psychiatr 1986 143 2 131 139 3080906
14. Assessing predictive factors for extended hospitalization at acute psychiatric admission. Hopko DR, Lachar D, Bailley SE, Varner RV, Psychiatr Serv 2001 52 10 1367 1373 10.1176/appi.ps.52.10.1367 11585954
15. Predicting length of stay on an acute care medical psychiatric inpatient service. Blais MA, Matthews J, Lipkis-Orlando R, Lechner E, Jacobo M, Lincoln R, et al. Admin Pol Ment Health 2003 31 1 15 29 10.1023/A:1026044106172
16. The metabolic syndrome and schizophrenia. Meyer JM, Stahl SM, Acta Psychiatr Scand 2009 119 1 4 14 10.1111/j.1600-0447.2008.01317.x 19133915
17. Prevalence of the metabolic syndrome in patients with schizophrenia treated with antipsychotic medication. De Hert MA, van Winkel R, Van Eyck D, Hanssens L, Wampers M, Scheen A, et al. Schizophr Res 2006 83 1 87 93 10.1016/j.schres.2005.12.855 16481149
18. The prevalence of the metabolic syndrome in psychiatric inpatients with primary psychotic and mood disorders. Bermudes RA, Keck PE Jr, Welge JA, Psychosomatics 2006 47 6 491 497 Schizophr Res 1 10.1176/appi.psy.47.6.491 17116950
19. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia. O'Keane V, J Psychopharmacol 2008 22 2 70 75 10.1177/0269881107088439 18477623
20. Endocrine disorders in schizophrenia: relationship to antipsychotic therapy. Aina Y, Nandagopol J, Nasrallah H, Curr Psychosis and Ther Rep 2004 2 2 78 83 10.1007/s11922-004-0035-4
21. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management. Holt RIG, Peveler RC, Clin Endocrinol 2011 74 2 141 147 10.1111/j.1365-2265.2010.03814.x
22. Association of Schizophrenia and autoimmune diseases: linkage of danish national registers. Eaton WW, Byrne M, Ewald H, Mors O, Chen C-Y, Agerbo E, et al. Am J Psychiatr 2006 163 3 521 528 10.1176/appi.ajp.163.3.521 16513876
23. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia. Poyraz B Aksoy C, BalcIoglu I, Eur Neuropsychopharmacol 2008 18 9 667 672 10.1016/j.euroneuro.2008.04.014 18539008
24. High prevalence of thyroid function test abnormalities in chronic schizophrenia. Othman SS, Kadir KA, Hassan J, Hong GK, Singh BB, Raman N, Aust New Zeal J Psychiatr 1994 28 4 620 624 10.3109/00048679409080785
25. Is autoimmune thyroiditis part of the genetic vulnerability (or an Endophenotype) for bipolar disorder? Vonk R, van der Schot AC, Kahn RS, Nolen WA, Drexhage HA, Biol Psychiatr 2007 62 2 135 140 10.1016/j.biopsych.2006.08.041
26. A Five-Year study on the interactive effects of depression and physical illness on psychiatric unit length of stay. Sloan DM, Yokley J, Gottesman H, Schubert DSP, Psychosom Med 1999 61 1 21 25 10024064
27. Impact of the interaction of depression and physical illness on a psychiatric units length of stay. Schubert DSP, Yokley J, Sloan D, Gottesman H, Gen Hosp Psychiatr 1995 17 5 326 334 10.1016/0163-8343(95)00065-Y
28. Elements of a successful short-stay inpatient psychiatric service. Jayaram G, Tien A, Sullivan P, Gwon H, Psychiatr Serv 1996 47 4 407 412 8689373
29. The role of psychometric data in predicting inpatient mental health service utilization. Averill PM, Hopko DR, Small DR, Greenlee HB, Varner RV, Psychiatr Q 2001 72 3 215 235 10.1023/A:1010396831037 11467156
30. Predicting inpatient length of stay with the expanded version of the brief psychiatric rating scale (Version 4.0). Anderson SW, Crist AJ, Payne N, Psychiatr Serv 2004 55 1 77 79 10.1176/appi.ps.55.1.77 14699205
31. The BPRS-E as predictor of length of stay in a residential facility. Biancosino B, Barbui C, Grassi L, Psychiatr Serv 2005 56 6 755 756 10.1176/appi.ps.56.6.755 15939961
32. Healthcare in schizophrenia: effectiveness and progress of a redesigned care network. Tzeng D-S, et al. BMC Health Serv Res 2007 7 1 129 10.1186/1472-6963-7-129 17705853
33. General hospital psychiatry and the new behavioral health care delivery system. Geraty RD, Gen Hosp Psychiatr 1995 17 4 245 250 10.1016/0163-8343(95) 00038-S
34. Observed-predicted length of stay for an acute psychiatric department, as an indicator of inpatient care inefficiencies. Retrospective case-series study. Jimenez R, Lam R, Marot M, Delgado A, BMC Health Serv Res 2004 4 1 4 10.1186/1472-6963-4-4 15102334
35. A statistical model for length of psychiatric in-patient treatment and an analysis of contributing factors. Stevens A, Hammer K, Buchkremer G, Acta Psychiatr Scand 2001 103 3 203 211 10.1034/j.1600-0447.2001.00043.x 11240577
36. WHO, ICD-10 international statistical classification of diseases and related health problems Geneva: World Health Organization 2007
37. American Psychiatric Association, Diagnostic and statistical manual of mental disorders: DSM-IV-TR. 4., text revision Washington: American Psychiatric Association 2000
38. Guidelines for rating Global Assessment of Functioning (GAF). Aas IHM, Ann Gen Psychiatr 2011 10 1 2 12 10.1186/1744-859X-10-2
39. A standardized and reliable method to apply the Global Assessment of Functioning (GAF) scale to psychiatric case records. Mirandola M, Baldassari E, Beneduce R, Italo A, Segala M, Tansella M, Int J Meth Psychiatr Res 2000 9 2 79 86 10.1002/mpr.82
40. The concurrent validity of the Global Assessment of Functioning (GAF). Startup M, Jackson MC, Bendix S, Br J Clin Psychol 2002 41 4 417 422 10.1348/014466502760387533 12437796
41. A brief mental health outcome scale-reliability and validity of the Global Assessment of Functioning (GAF). Jones S, Thornicroft G, Coffey M, Dunn G, Br J Psychiatr 1995 166 5 654 659 10.1192/bjp.166.5.654
42. Component structure of the expanded Brief Psychiatric Rating Scale (BPRS-E). Dingemans P, Linszen D, Lenior M, Smeets R, Psychopharmacology 1995 122 3 263 267 10.1007/BF02246547 8748395
43. Sensitivity to change of the Brief Psychiatric Rating Scale-Extended (BPRS-E): An item and subscale analysis. Burlingame GM, Seaman S, Johnson JE, Whipple J, Richardson E, Rees F, et al. Psychol Serv 2006 3 2 77 87
44. A rating scale for depression. Hamilton M, J Neurol Neurosurg Psychiatr 1960 23 56 62 10.1136/jnnp.23.1.56 14399272
45. Development of a rating scale for primary depressive illness. Hamilton M, Br J Soc Clin Psychol 1967 6 4 278 296 10.1111/j.2044-8260.1967.tb00530.x 6080235
46. Inter-rater reliability of the Hamilton depression rating scale as a diagnostic and outcome measure of depression in primary care. Morriss R, Leese M, Chatwin J, Baldwin D, J Affect Disord 2008 111 2-3 204 213 18374987
47. Assessment of mood: Guides for clinicians. Furukawa TA, J Psychosom Res 2010 68 6 581 589 10.1016/j.jpsychores.2009.05.003 20488276
48. Validity and reliability of the Chinese Hamilton Depression Rating Scale. Zheng Y, Zhao J, Phillips M, Liu J, Cai M, Sun S, et al. Br J Psychiatr 1988 152 5 660 664 10.1192/bjp.152.5.660